characteristics.text: ERC000011
characteristics.characteristic: ENA-CHECKLIST
characteristics.text: 2022-08-24T20:20:52Z
characteristics.characteristic: ENA-FIRST-PUBLIC
characteristics.text: 2022-08-24T20:20:52Z
characteristics.characteristic: ENA-LAST-UPDATE
characteristics.text: SAMEA110703497
characteristics.characteristic: External Id
characteristics.text: KAUST
characteristics.characteristic: INSDC center name
characteristics.text: 2022-08-24T20:20:52Z
characteristics.characteristic: INSDC first public
characteristics.text: 2022-08-24T20:20:52Z
characteristics.characteristic: INSDC last update
characteristics.text: public
characteristics.characteristic: INSDC status
characteristics.text: ERS12801034
characteristics.characteristic: SRA accession
characteristics.text: ena-SAMPLE-TAB-24-08-2022-15:55:28:200-29157
characteristics.characteristic: Submitter Id
characteristics.text: GDPD:loxPint B4 line treated with RAP and supplemented with choline
characteristics.characteristic: description
characteristics.text: Plasmodium falciparum 3D7
characteristics.characteristic: organism
characteristics.text: Plasmodium falciparum 3D7
characteristics.characteristic: scientific_name
characteristics.text: B4_RAP_choline_2
characteristics.characteristic: title